If they were going to start a combo trial with a CI within a few months... really going to start one in a few months (lol!)... then I think they'd move forward with the one that's already primed and ready to go. But I could be wrong. However, I think they received some of their grant money from NCI to move forward on the Nivo combo trial so... there's that.
Oh... back to your question about the neoadjuvant trial... yes... she did say Nivo - not Keytruda.
I was transcribing the trial, and I think that this point was right around the time that you posted the broken up transcription from that program (which I subsequently downloaded). Anyhow, I missed a statement right before Nivo (which she does say instead of Keytruda - oops) I think because I was deleting the times that accompanied your transcription.
We also just recently… Tim Cloughesy, who's our neuro-oncologist, and our group, recently published a paper in Nature Medicine just
The above sentence in red is what I'd missed.
I'll post the entire transcription next. I definitely benefited from using your's, and I just edited it as I went a long listening to the actual presentation. Quite a few funny interpretations of what she'd said in there, as you indicated. :)